Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1642928A details novel routes for high-purity morpholine derivatives. Discover cost-effective enzymatic and chiral pool strategies for API manufacturing.
Patent CN1759097A details a safer process for PDF inhibitor intermediates using specific beta-lactams and selective debenzylation, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel chiral auxiliary method for rasagiline production offering high yield and reduced pollution for pharmaceutical manufacturers seeking reliable supply chains.
Patent CN101003549B discloses a robust synthesis of planar chiral [2.2]paracyclophane phosphines via cyclopalladium resolution, offering high stability for pharmaceutical intermediates.
Patent CN113717178A discloses a scalable method for chiral 7-azabicyclo[2.2.1]heptane intermediates, offering improved purity and cost efficiency for oncology drug manufacturing.
Patent CN102728407B details a waste-utilizing synthesis for chiral salen catalysts, offering cost reduction in pharmaceutical intermediate manufacturing via single-solvent processes.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN110804062B details a high-yield synthesis of chiral lactone for biotin. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel asymmetric conversion method boosts yield to over 80 percent for L-2-aminobutyric acid, offering cost-effective pharma intermediate supply.
Novel nickel-catalyzed hydrogenation and lipase resolution method for high-purity 1-acenaphthenol. Enhances safety and yield for global pharmaceutical supply chains effectively.
Patent CN102212081B details a novel asymmetric synthesis for statin side chains, offering high purity and eliminating resolution steps for cost-effective manufacturing.
Patent CN1100410A details a novel route for (+)-2-(3,4-dichlorophenyl)-4-hydroxybutylamine using N-methylglucamine resolution and borane reduction for high-purity tachykinin antagonists.
Novel patent CN115160158B details a reducing-agent-free route for high-purity chiral tertiary leucinol, offering significant supply chain stability and cost optimization for pharmaceutical manufacturing.
Patent CN111875577B details a one-pot synthesis of high-purity R-propylene carbonate using recyclable S-salen Co(II), offering significant cost and waste reduction for API manufacturers.
Novel Co(III) catalyzed route for Oteseconazole offers high ee value and safety. Reliable supply chain partner for scalable antifungal intermediate manufacturing.
Patent CN110467537B reveals a streamlined 6-step synthesis for L-p-hydroxyphenylglycine, offering significant cost reduction and yield improvements for antibiotic manufacturers.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.
Patent CN100432060C details advanced synthesis of levofloxacin intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chiral resolution.
Discover the asymmetric transformation method for L-2-aminobutanamide hydrochloride. Enhance purity and reduce costs in levetiracetam manufacturing with our advanced synthesis route.
Patent CN114716375A details a novel chiral resolution process achieving >99.9% optical purity for Mivacurium intermediates, ensuring superior safety and scalable manufacturing.